Target intelligence / Profile preview

Stromal vascular fraction cell population (SVF)

Target
SVF
Molecular classification
Other
01

Overview

The stromal vascular fraction (SVF) cell population is a heterogeneous collection of cells isolated from adipose (fat) tissue, typically obtained through enzymatic digestion and centrifugation of lipoaspirate[1][5][6]. It is not a single defined molecular target or receptor, but rather a mixture containing adipose-derived stem cells (ADSCs), endothelial cells, endothelial progenitor cells, pericytes, immune cells (including T cells, monocytes/macrophages, and lymphocytes), and other stromal cells[3][5][6]. The SVF is characterized by a combination of cell surface markers such as CD34, CD31, CD45, CD73, CD90, and CD105, which are used to distinguish its various cellular subsets[1][3][6]. SVF is mainly employed in regenerative medicine and tissue engineering due to its potential to support tissue repair, stimulate angiogenesis, modulate inflammation, and differentiate into multiple lineages (osteogenic, chondrogenic, adipogenic, etc.)[2][5][6][7]. It has been investigated in various clinical contexts including cardiovascular, neurologic, autoimmune, orthopedic, and degenerative diseases. However, SVF as a whole is not a classical drug target (e.g., receptor or enzyme), but instead serves as a therapeutic cell population or biologic product. Its use raises challenges regarding heterogeneity, standardization of preparation, and long-term safety[6][7]. Because "stromal vascular fraction cell population" refers to a complex mixture of cells, and not a single, defined molecule or drug target, it is not technically considered a therapeutic target such as a receptor, enzyme, or transporter. Instead, it is the source population for multiple regenerative and modulatory cells used experimentally and clinically in cell therapy applications[7].

Other names
Stromal vascular fractionAdipose-derived stromal vascular fractionSVF cell populationAdipose-derived SVFAD-SVF
02

Mechanism of action

Paracrine secretion of cytokines, chemokines, and growth factors (e.g., VEGF, TGF-β, HGF) that stimulate regeneration and angiogenesis - Multilineage differentiation of stem/progenitor cells - Immunomodulatory activity via interaction with immune cells[2][5][6][7]

03

Biological functions

Tissue regenerationAngiogenesis (formation of new blood vessels)Immune modulationStem/progenitor cell supportHomeostasis maintenance
04

Disease associations

Degenerative diseasesCardiovascular diseaseNeurologic diseaseAutoimmune disordersOrthopedic disordersPulmonary diseaseOphthalmologic diseaseCancer (investigational)Inflammation
05

Safety considerations

Heterogeneity of cell populations leading to variable therapeutic outcomesLong-term efficacy and safety not fully established[6]Potential for unwanted differentiation or ectopic tissue formation
06

Biomarkers

CD34, CD31, CD45, CD73, CD90, CD105 (cell surface markers characterizing subpopulations)[1][3][6]

Beyond the preview

Go deeper on Stromal vascular fraction cell population (SVF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stromal vascular fraction cell population (SVF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call